NO970889D0 - Nye peptidderivater med <delta> opioid-reseptorantagonist- eller blandet <my> agonist/<delta> antagonist-effekt - Google Patents

Nye peptidderivater med <delta> opioid-reseptorantagonist- eller blandet <my> agonist/<delta> antagonist-effekt

Info

Publication number
NO970889D0
NO970889D0 NO970889A NO970889A NO970889D0 NO 970889 D0 NO970889 D0 NO 970889D0 NO 970889 A NO970889 A NO 970889A NO 970889 A NO970889 A NO 970889A NO 970889 D0 NO970889 D0 NO 970889D0
Authority
NO
Norway
Prior art keywords
parta
antagonist
agonist
mixed
opioid receptor
Prior art date
Application number
NO970889A
Other languages
English (en)
Other versions
NO970889L (no
Inventor
Peter Schiller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO970889L publication Critical patent/NO970889L/no
Publication of NO970889D0 publication Critical patent/NO970889D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO970889A 1994-08-30 1997-02-27 Nye peptidderivater med <delta> opioid-reseptorantagonist- eller blandet <my> agonist/<delta> antagonist-effekt NO970889D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402880A SE9402880D0 (sv) 1994-08-30 1994-08-30 New peptide derivatives
PCT/SE1995/000918 WO1996006855A1 (en) 1994-08-30 1995-08-10 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS

Publications (2)

Publication Number Publication Date
NO970889L NO970889L (no) 1997-02-27
NO970889D0 true NO970889D0 (no) 1997-02-27

Family

ID=20395061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970889A NO970889D0 (no) 1994-08-30 1997-02-27 Nye peptidderivater med <delta> opioid-reseptorantagonist- eller blandet <my> agonist/<delta> antagonist-effekt

Country Status (12)

Country Link
US (1) US5811400A (no)
EP (1) EP0776332A1 (no)
JP (1) JPH10504837A (no)
CA (1) CA2197566A1 (no)
FI (1) FI970823A0 (no)
IL (1) IL114664A0 (no)
NO (1) NO970889D0 (no)
NZ (1) NZ292287A (no)
SE (1) SE9402880D0 (no)
TR (1) TR199501076A2 (no)
WO (1) WO1996006855A1 (no)
ZA (1) ZA956561B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
SE9604789D0 (sv) * 1996-12-20 1996-12-20 Astra Ab New Compounds
US6465479B1 (en) * 1999-08-13 2002-10-15 Southern Research Institute Pyridomorphinans and use thereof
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US6916905B2 (en) * 2000-03-24 2005-07-12 The United States Of America As Represented By The Department Of Health And Human Services Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use
US6753317B1 (en) 2000-03-24 2004-06-22 The United States Of America As Represented By The Department Of Health And Human Services Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use
CZ20031422A3 (cs) 2000-10-30 2004-01-14 Janssen Pharmaceutica N. V. Inhibitory tripeptidylpeptidázy
US7041681B2 (en) 2002-04-29 2006-05-09 Janssen Pharmaceutica N.V. Compounds as opioid receptor modulators
ES2428008T3 (es) 2004-03-15 2013-11-05 Janssen Pharmaceutica Nv Moduladores de receptores opioides
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US20060104907A1 (en) * 2004-11-16 2006-05-18 Government Of The U.S.A., Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use
US8030341B2 (en) * 2005-09-01 2011-10-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Dmt-derivative compounds and related compositions and methods of use
WO2008016913A1 (en) * 2006-07-31 2008-02-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the dmt-tic pharmacophore and methods of use
TWI468375B (zh) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv 製備經保護之l-丙胺酸衍生物之方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds

Also Published As

Publication number Publication date
FI970823A (fi) 1997-02-27
FI970823A0 (fi) 1997-02-27
NO970889L (no) 1997-02-27
ZA956561B (en) 1996-02-29
JPH10504837A (ja) 1998-05-12
WO1996006855A1 (en) 1996-03-07
US5811400A (en) 1998-09-22
AU3401695A (en) 1996-03-22
TR199501076A2 (tr) 1996-06-21
NZ292287A (en) 1998-02-26
EP0776332A1 (en) 1997-06-04
CA2197566A1 (en) 1996-03-07
SE9402880D0 (sv) 1994-08-30
IL114664A0 (en) 1995-11-27
AU695175B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
NO974686D0 (no) Nye substituerte piperazinderivater med tachykinin reseptor antagonist aktivitet
DK0804419T3 (da) Quinolinderivater som tachykinin NK 3-receptor-antagonister
NO20023729D0 (no) Preparater med regulert frigivelse inneholdende opioidagonist og -antagonist
NO970889D0 (no) Nye peptidderivater med &lt;delta&gt; opioid-reseptorantagonist- eller blandet &lt;my&gt; agonist/&lt;delta&gt; antagonist-effekt
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
KR950700304A (ko) 5ht4-수용체 길항질로서 축합 인돌 유도체(condensed indole derivatives as 5ht4-receptor antagonists)
ATE357443T1 (de) Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
NO960081L (no) Östrogen-agonist/antagonister
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
DE69740099D1 (de) Transdermale zusammenstellung mit serotoninrezeptor-antagonist
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
ATE196766T1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
DE69920518D1 (de) Vitronectin rezeptor antagonist
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
ATE206421T1 (de) Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten
NO950684D0 (no) Nye imidazopyridinderivater som angiotensinII-antagonister
NO964670D0 (no) Nye opioidpeptidanaloger med blandete my agonist/ antagonist-egenskaper

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application